he range of 0.0078--4 µg/mL for all isolates.

2.3. In Vitro Antifungal Susceptibility Testing {#sec2dot3-jof-03-00020}
-----------------------------------------------

Antifungal susceptibility testing was done according to the CLSI-M38-A2 guidelines following the broth microdilution method described by the Clinical and Laboratory Standards Institute (CLSI) \[[@B25-jof-03-00020]\]. The fungal growth medium used was the synthetic broth medium RPMI-1640 with L-glutamine, without sodium bicarbonate and with phenol red as a pH indicator (HiMedia Laboratories, Mumbai, India) buffered to a pH of 7.0 at 25 °C using MOPS (3-\[*N*-morpholino\] propanesulfonic acid) buffer (Sigma-Aldrich, St. Louis, MO, USA). A saline spore suspension of a ten-day-old well-sporulated culture on Potato Dextrose Agar (PDA) slant (HiMedia Laboratories Pvt. Ltd., Mumbai, India) was used for inoculum preparation. With the turbidity of the saline spore suspension adjusted to 0.5 McFarland Turbidity Standard (Appendix C section of CLSI M38-A2)., it was then further diluted 1:50 times (for moulds) and 1:500 (for yeasts) in RPMI-1640 with [l]{.smallcaps}-glutamine and without sodium bicarbonate This served as the final inoculum and 0.1 mL i.e., 100 µL of this inoculum suspension and 100 µL of the antifungal drug dilutions were added to the wells of the microdilution plates. Each drug was designated one row in the plate with each well in the row for a particular drug concentration. The growth control well contained 100 µL of the inoculum and 100 µL of the drug diluent without antifungal agent. Sterility control was also included with plain RPMI-1640 medium without inoculum. *Paecilomyces variotii* CBS 132734 was included in the tests as a quality control strain. The plates were incubated at 35 °C and the readings were taken after 48 h of incubation. The first well showing 100% inhibition of growth in the case of moulds and 50% inhibition of growth in the case of yeasts were taken as the Minimum Inhibitory Concentration (MIC). Susceptibility 